Stockscreener 앱 받기
1.095
1.85%
0.015
전일 마감가:
$1.08
열려 있는:
$1.08
하루 거래량:
223.40K
Relative Volume:
0.32
시가총액:
$109.67M
수익:
-
순이익/손실:
$-21.65M
주가수익비율:
-3.2972
EPS:
-0.3321
순현금흐름:
$-15.84M
1주 성능:
+14.92%
1개월 성능:
+5.77%
6개월 성능:
-21.43%
1년 성능:
-23.08%
1일 변동 폭
$1.0739
$1.10
1주일 범위
$0.95
$1.12
52주 변동 폭
$0.7709
$1.59
Cardiol Therapeutics Inc Stock (CRDL) Company Profile
명칭
Cardiol Therapeutics Inc
전화
-
주소
-
CRDL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRDL
Cardiol Therapeutics Inc
|
1.0967 | 108.00M | 0 | -21.65M | -15.84M | -0.3321 |
|
ZTS
Zoetis Inc
|
119.56 | 52.03B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.52 | 45.40B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.625 | 42.13B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.86 | 34.19B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
486.74 | 20.88B | 3.08B | 1.24B | 1.07B | 25.61 |
Cardiol Therapeutics Inc Stock (CRDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 개시 | H.C. Wainwright | Buy |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-06-26 | 개시 | ROTH MKM | Buy |
| 2024-04-22 | 개시 | H.C. Wainwright | Buy |
Cardiol Therapeutics Inc 주식(CRDL)의 최신 뉴스
Investors in cash trouble should check out Cardiol Therapeutics Inc (CRDL) - Setenews
Inflation Data: Will Cardiol Therapeutics Inc CT9 stock outperform small cap peersMarket Activity Report & Fast Entry Momentum Alerts - BỘ NỘI VỤ
(CRDL) Investment Analysis and Advice (CRDL:CA) - news.stocktradersdaily.com
Is Cardiol Therapeutics Inc. stock a defensive play in 2025July 2025 Analyst Calls & Safe Entry Point Alerts - Newser
Cardiol Therapeutics Reports Q3 2025 Financial Results Amidst Cash Decrease - MSN
(CRDL) Market Dynamics and Trading Signals (CRDL:CA) - news.stocktradersdaily.com
How buyback programs support Cardiol Therapeutics Inc. (CT9) stockAnalyst Upgrade & Proven Capital Preservation Tips - Newser
Why institutional investors increase stakes in Cardiol Therapeutics Inc. (CT9) stock2025 Retail Activity & Free Real-Time Market Sentiment Alerts - Newser
Should you sell your Cardiol Therapeutics stock? - Cantech Letter
Is Cardiol Therapeutics Inc. stock attractive for passive investorsMarket Performance Summary & Consistent Growth Stock Picks - Newser
Will Cardiol Therapeutics Inc. (CT9) stock announce special dividendWeekly Profit Recap & Daily Volume Surge Signals - Newser
Will Cardiol Therapeutics Inc. (CT9) stock issue positive guidanceJuly 2025 Action & Risk Controlled Swing Trade Alerts - Newser
What hedge fund moves indicate for Cardiol Therapeutics Inc. (CT9) stockMarket Movement Recap & Safe Entry Zone Identification - Newser
Will Cardiol Therapeutics Inc. stock deliver consistent dividendsJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser
What RSI levels show for Cardiol Therapeutics Inc. (CT9) stock2025 Trading Recap & Consistent Growth Stock Picks - Newser
Taking the lead: Cardiol Therapeutics Inc (CRDL) - Setenews
Cardiol Therapeutics (TSE:CRDL) Stock Price Down 14.6%Should You Sell? - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 14.6%Should You Sell? - MarketBeat
Will Cardiol Therapeutics Inc. (CT9) stock recover faster than industryJuly 2025 PreEarnings & Verified Momentum Stock Watchlist - Newser
Cardiol Therapeutics (TSE:CRDL) Shares Down 14.6%Here's What Happened - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Shares Down 17.2%Here's What Happened - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Shares Down 13.9%What's Next? - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 17.2%Here's What Happened - MarketBeat
Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright - MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Down 7.9%Here's Why - MarketBeat
H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target - Investing.com Nigeria
H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target By Investing.com - Investing.com South Africa
Is Cardiol Therapeutics Inc. (CT9) stock a top dividend aristocrat candidateGold Moves & Short-Term Trading Alerts - Newser
Why Cardiol Therapeutics Inc. stock appeals to analystsTrade Volume Report & Safe Entry Zone Identification - Newser
Cardiol Therapeutics’ (CRDL) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
HC Wainwright & Co. Reiterates Cardiol Therapeutics (CRDL) Buy Recommendation - Nasdaq
CRDL.NE Interactive Stock Chart | CARDIOL THERAPEUTICS INC Stock - Yahoo! Finance Canada
Cardiol Therapeutics (CRDL): HC Wainwright & Co. Reiterates Buy Rating | CRDL Stock News - GuruFocus
CRDL Analyst Forecasts - Quiver Quantitative
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx(TM) Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions - TipRanks
Cardiol Therapeutics reports positive Phase II myocarditis trial results By Investing.com - Investing.com Nigeria
Cardiol Therapeutics Reports Positive Phase II ARCHER Trial Results for CardiolRx™ - TipRanks
CARDIOL THERAPEUTICS INC (CRDL.NE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cardiol Therapeutics reports positive Phase II myocarditis trial results - Investing.com
New Data from the Phase II ARCHER Trial Demonstrate CardiolRx Improves Heart Structure in Patients with Acute Myocarditis, Supporting Expansion Across Inflammatory Cardiac Conditions - Investing News Network
Cardiol Therapeutics (NASDAQ: CRDL) posts Phase II ARCHER myocarditis recovery data - Stock Titan
(CRDL) Stock Analysis and Trading Signals (CRDL:CA) - news.stocktradersdaily.com
What is Cardiol Therapeutics Inc (CRDL) Stock Return on Shareholders’ Capital? - Setenews
Cardiol Therapeutics Inc (CRDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.84%
0.66%
자본화:
|
볼륨(24시간):